https://www.walshcardiogenomics.org https://www.walshcardiogenomics.org/publications https://www.walshcardiogenomics.org/projects https://www.walshcardiogenomics.org/people https://www.walshcardiogenomics.org/courses https://www.walshcardiogenomics.org/posts https://www.walshcardiogenomics.org/pages https://www.walshcardiogenomics.org/cv https://www.walshcardiogenomics.org/contact_form https://www.walshcardiogenomics.org/publications/68277-whole-genome-sequencing-implicates-rare-low-frequency-and-structural-non-coding-variation-at-the-scn5a-locus-in-brugada-syndrome https://www.walshcardiogenomics.org/publications/70319-an-updated-evidence-assessment-of-the-genetic-causes-of-dilated-cardiomyopathy https://www.walshcardiogenomics.org/publications/68275-intermediate-effect-variants-in-hcm-integration-into-clinical-practice-and-family-screening https://www.walshcardiogenomics.org/publications/68279-automated-patch-clamp-data-improve-variant-classification-and-penetrance-stratification-for-scn5a-brugada-syndrome https://www.walshcardiogenomics.org/publications/68280-brugada-syndrome-an-exemplar-for-the-genomic-basis-of-sudden-death https://www.walshcardiogenomics.org/publications/68293-a-rare-noncoding-enhancer-variant-in-scn5a-contributes-to-the-high-prevalence-of-brugada-syndrome-in-thailand https://www.walshcardiogenomics.org/publications/68278-large-scale-genome-wide-association-analyses-identify-novel-genetic-loci-and-mechanisms-in-hypertrophic-cardiomyopathy https://www.walshcardiogenomics.org/publications/68288-evaluation-of-polygenic-scores-for-hypertrophic-cardiomyopathy-in-the-general-population-and-across-clinical-settings https://www.walshcardiogenomics.org/publications/68281-redefining-the-genetic-architecture-of-hypertrophic-cardiomyopathy-role-of-intermediate-effect-variants https://www.walshcardiogenomics.org/publications/68248-clingen-hereditary-cardiovascular-disease-gene-curation-expert-panel-reappraisal-of-genes-associated-with-hypertrophic-cardiomyopathy https://www.walshcardiogenomics.org/publications/68400-titin-and-the-mystery-of-cardiomyopathy-incidence https://www.walshcardiogenomics.org/publications/68401-navigating-the-complex-path-from-monogenic-to-polygenic-clinical-genetic-testing-in-hypertrophic-cardiomyopathy https://www.walshcardiogenomics.org/publications/68282-genome-wide-association-study-reveals-mechanisms-underlying-dilated-cardiomyopathy-and-myocardial-resilience https://www.walshcardiogenomics.org/publications/68252-exploring-the-complex-spectrum-of-dominance-and-recessiveness-in-genetic-cardiomyopathies https://www.walshcardiogenomics.org/publications/68395-emery-dreifuss-muscular-dystrophy-a-closer-look-at-cardiac-complications https://www.walshcardiogenomics.org/publications/68255-ethnicity-consanguinity-and-genetic-architecture-of-hypertrophic-cardiomyopathy https://www.walshcardiogenomics.org/publications/68250-the-trouble-with-trabeculation-how-genetics-can-help-to-unravel-a-complex-and-controversial-phenotype https://www.walshcardiogenomics.org/publications/68254-genome-wide-association-studies-of-cardiovascular-disease https://www.walshcardiogenomics.org/publications/68256-genome-wide-association-analyses-identify-novel-brugada-syndrome-risk-loci-and-highlight-a-new-mechanism-of-sodium-channel-regulation-in-disease-susceptibility https://www.walshcardiogenomics.org/publications/68396-first-steps-of-population-genomic-medicine-in-the-arrhythmia-world-pros-and-cons https://www.walshcardiogenomics.org/publications/68294-an-evidence-based-assessment-of-genes-in-dilated-cardiomyopathy https://www.walshcardiogenomics.org/publications/68257-systematic-large-scale-assessment-of-the-genetic-architecture-of-left-ventricular-noncompaction-reveals-diverse-etiologies https://www.walshcardiogenomics.org/publications/68258-shared-genetic-pathways-contribute-to-risk-of-hypertrophic-and-dilated-cardiomyopathies-with-opposite-directions-of-effect https://www.walshcardiogenomics.org/publications/68397-desmin-variants-in-cardiomyopathies-the-hard-yards-in-defining-pathogenicity https://www.walshcardiogenomics.org/publications/68249-evaluation-of-gene-validity-for-cpvt-and-short-qt-syndrome-in-sudden-arrhythmic-death https://www.walshcardiogenomics.org/publications/68398-alpk3-a-full-spectrum-cardiomyopathy-gene https://www.walshcardiogenomics.org/publications/68259-minor-hypertrophic-cardiomyopathy-genes-major-insights-into-the-genetics-of-cardiomyopathies https://www.walshcardiogenomics.org/publications/68260-new-variant-with-a-previously-unrecognized-mechanism-of-pathogenicity-in-hypertrophic-cardiomyopathy https://www.walshcardiogenomics.org/publications/68267-genetic-studies-of-hypertrophic-cardiomyopathy-in-singaporeans-identify-variants-in-tnni3-and-tnnt2-that-are-common-in-chinese-patients https://www.walshcardiogenomics.org/publications/68266-contemporary-insights-into-the-genetics-of-hypertrophic-cardiomyopathy-toward-a-new-era-in-clinical-testing https://www.walshcardiogenomics.org/publications/68263-reevaluating-the-genetic-contribution-of-monogenic-dilated-cardiomyopathy https://www.walshcardiogenomics.org/publications/68268-transethnic-genome-wide-association-study-provides-insights-in-the-genetic-architecture-and-heritability-of-long-qt-syndrome-running-title-genome-wide-association-study-in-long-qt-syndrome https://www.walshcardiogenomics.org/publications/68262-common-and-rare-susceptibility-genetic-variants-predisposing-to-brugada-syndrome-in-thailand https://www.walshcardiogenomics.org/publications/68265-enhancing-rare-variant-interpretation-in-inherited-arrhythmias-through-quantitative-analysis-of-consortium-disease-cohorts-and-population-controls https://www.walshcardiogenomics.org/publications/68261-when-genetic-burden-reaches-threshold https://www.walshcardiogenomics.org/publications/68269-evaluating-the-clinical-validity-of-hypertrophic-cardiomyopathy-genes https://www.walshcardiogenomics.org/publications/68399-scn5a-variants-in-brugada-syndrome-true-true-false-or-false-true https://www.walshcardiogenomics.org/publications/68270-quantitative-approaches-to-variant-classification-increase-the-yield-and-precision-of-genetic-testing-in-mendelian-diseases-the-case-of-hypertrophic-cardiomyopathy https://www.walshcardiogenomics.org/publications/68271-defining-the-genetic-architecture-of-hypertrophic-cardiomyopathy-re-evaluating-the-role-of-non-sarcomeric-genes https://www.walshcardiogenomics.org/publications/68289-using-high-resolution-variant-frequencies-to-empower-clinical-genome-interpretation https://www.walshcardiogenomics.org/publications/68272-reassessment-of-mendelian-gene-pathogenicity-using-7-855-cardiomyopathy-cases-and-60-706-reference-samples https://www.walshcardiogenomics.org/publications/68273-paralogue-annotation-identifies-novel-pathogenic-variants-in-patients-with-brugada-syndrome-and-catecholaminergic-polymorphic-ventricular-tachycardia https://www.walshcardiogenomics.org/publications/68274-paralogous-annotation-of-disease-causing-variants-in-long-qt-syndrome-genes https://www.walshcardiogenomics.org/pages/9946-contact